Close Menu

NEW YORK – S2 Genomics said on Wednesday that it has signed distribution agreements with Scrum, PharmiGene, LnCBio, Thunderbio Science, and TrendBio to promote, sell, and support S2's Singulator 100 system as well as associated products for single-cell genomics and cell biology applications in the Asia-Pacific region.

The firm's agreements will cover Japan (Scrum), South Korea, (LnCBio and Thunderbio Science), Taiwan (PharmiGene), as well as Australia and New Zealand (TrendBio).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.